In this regard, we recently proposed an oncogenic cascade where both CK2 and NCoR selectively repress the transcription of a sub-set of target genes including the anti-tumorigenic gene interferon-γ-inducible protein 10 (IP-10), to promote oncogenic signaling in human cancer cells [18]. The gene discussed is CXCL10; the disease is cancer.